Publications

5674 Results

Phase II trial of single agent carboplatin followed by dose-intense paclitaxel, followed by maintenance paclitaxel therapy in stage IV ovarian, fallopian tube, and peritoneal cancers: a Southwest Oncology Group trial

Authors
M Markman;T Glass;HO Smith;KD Hatch;GR Weiss;SA Taylor;JW Goodwin;DS Alberts
Journal / Conference
Gynecologic Oncology 88:282-288
Year
2003
Research Committee(s)
Gynecologic
Study Number(s)
S9618

An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer

Authors
DJ Adelstein;Y Li;GL Adams;H Wagner Jr;JA Kish;JF Ensley;DE Schuller;AA Forastiere
Journal / Conference
Journal of Clinical Oncology 21(1):92-98
Year
2003
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-9059 (E-1392) (INT-0126)

Gene expression profile of serial samples of transformed B-cell lymphomas.

Authors
S de Vos;WK Hofmann;TM Grogan;U Krug;M Schrage;TP Miller;J Braun;W Wachsman;HP Koeffler;JH Said
Journal / Conference
Laboratory Investigation 83(2):271-285
Year
2003
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8819

Adenoma recurrences after resection of colorectal carcinoma: Results from the Southwest Oncology Group 9041 calcium chemoprevention pilot study

Authors
DZJ Chu;K Chansky;DS Alberts;FL Meyskens;CM Fenoglio-Preiser;SE Rivkin;GM Mills;JK Giguere;GE Goodman;JL Abbruzzese;SM Lippman
Journal / Conference
Annals of Surgical Oncology 10(8):870-875
Year
2003
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9041

High-dose ifosfamide with mesna and granuloctye-colony-stimulating factor (recombinant human G-CSF) in patients with unresectable malignant mesothelioma

Authors
SM Talbot;C Rankin;RN Taub;SP Balcerzak;N Bhoopalam;RA Chapman;LH Baker;EL Middleman;KH Antman
Journal / Conference
Cancer 98(2):331-336
Year
2003
Research Committee(s)
Sarcoma
Study Number(s)
SWOG-9341

Consolidation docetaxel after concurrent chemoradiotherapy in stage IIIB non-small-cell lung cancer: Phase II Southwest Oncology Group study S9504

Authors
DR Gandara;K Chansky;KS Albain;BR Leigh;LE Gaspar;PN Lara;H Burris;P Gumerlock;JP Kuebler;JD Bearden;J Crowley;R Livingston
Journal / Conference
Journal of Clinical Oncology 21(10):2004-2010
Year
2003
Research Committee(s)
Lung
Study Number(s)
SWOG-9504

Mevastatin can increase toxicity in primary AMLs exposed to standard therapeutic agents, but statin efficacy is not simply associated with ras hotspot mutations or overexpression

Authors
DL Stirewalt;FR Appelbaum;CL Willman;RA Zager;DE Banker
Journal / Conference
Leukemia Research 27:133-145
Year
2003
Research Committee(s)
Leukemia

Combined intraperitoneal and intravenous chemotherapy for women with optimally debulked ovarian cancer: Results from an Intergroup phase II trial

Authors
ML Rothenberg;PY Liu;PS Braley;SP Wilczynski;EV Hannigan;S Wadler;G Stuart;C Jiang;M Markman;DS Alberts
Journal / Conference
Journal of Clinical Oncology 21(7):1313-1319
Year
2003
Research Committee(s)
Gynecologic
Study Number(s)
S9619

Dose-intense chemotherapy every 2 weeks with dose-intense cyclophosphamide, doxorubicin, vincristine, and prednisone may improve survival in intermediate and high grade lymphoma: a phase II study of the Southwest Oncology Group (SWOG 9349)

Authors
DW Blayney;ML LeBlanc;T Grogan;ER Gaynor;RA Chapman;CH Spiridonidis;SA Taylor;SI Bearman;TP Miller;RI Fisher
Journal / Conference
Journal of Clinical Oncology 21(13):2466-2473
Year
2003
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8903, SWOG-9349

Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer

Authors
HB Grossman;RB Natale;CM Tangen;VO Speights;NJ Vogelzang;DL Trump;RW de Vere White;MF Sarosdy;DP Wood Jr;D Raghavan;ED Crawford
Journal / Conference
New England Journal of Medicine 349(9):859-866
Year
2003
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8710 (INT-0080) (EST-1887) (CALGB-8891)